Expert Exchange: UMKC Professor Utilizes Novel Technology for More Effective Immunotherapy
Bigger is not always better. When fighting cancer, Kun Cheng, PhD, Curators’ Distinguished Professor of Pharmacy at the University of Missouri – Kansas City (UMKC), the aim…
Continue Reading
KU Cancer Center Researchers Optimize the Immune System to Beat Cancer
Researchers are teaming up to take chimeric antigen receptor (CAR) T-cell therapy to the next level
CAR T-cell therapy amplifies the immune system’s ability to recognize…
Continue Reading
MU Research Offers Hope in Fight Against Blood Cancers
A groundbreaking process developed by researchers based in the Roy Blunt NextGen Precision Health Building offers new hope in the fight against blood cancers, such as lymph…
Continue Reading
KU Researcher & Parkville Patient Show the Promise of Gene-Editing Cancer Treatment
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. After undergoing a new form of experimental …
Continue Reading
Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
New Data Show Therapies May Activate Lymph Nodes to Produce Tumor-Tackling T Cells
Cancer treatment routinely involves removing lymph nodes near the tumor if they contai…